Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.68 |
| ▸ | MAOB | P27338 | 4/20 | 0.66 |
| ▸ | CA12 | O43570 | 4/20 | 0.66 |
| ▸ | CA9 | Q16790 | 4/20 | 0.66 |
| ▸ | TSHR | P16473 | 3/20 | 0.66 |
| ▸ | CA1 | P00915 | 1/20 | 0.66 |
| ▸ | CA3 | P07451 | 1/20 | 0.66 |
| ▸ | CA4 | P22748 | 1/20 | 0.66 |
| ▸ | CA6 | P23280 | 1/20 | 0.66 |
| ▸ | CA5A | P35218 | 1/20 | 0.66 |
| ▸ | CA7 | P43166 | 1/20 | 0.66 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.66 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.66 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.66 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.64 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.64 |
| ▸ | NT5E | P21589 | 1/20 | 0.64 |
| ▸ | MEN1 | O00255 | 4/20 | 0.62 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| 3-(2-Bromoacetyl)-Coumarin SCHEMBL30633043 | 1.00 | LMNA (0.68) | LMNAMAOBCA12CA9TSHR | |
| 3-(2-Bromoacetyl)-Coumarin SCHEMBL28782184 | 0.95 | KDM4E (0.68) | LMNAMAOBCA12CA9TSHR | |
| 3-(2-Bromoacetyl)-Coumarin SCHEMBL28678576 | 0.94 | LMNA (0.70) | LMNAMAOBCA12CA9TSHR | |
| SCHEMBL15842724 | 0.84 | LMNA (0.68) | LMNAMAOBCA12CA9TSHR | |
| SCHEMBL7349348 | 0.84 | LMNA (0.78) | LMNAMAOBCA12CA9TSHR | |
| SCHEMBL26656965 | 0.84 | LMNA (0.68) | LMNAMAOBCA12CA9TSHR | |
| Hydrochloric Acid SCHEMBL28525822 | 0.83 | LMNA (0.67) | LMNAMAOBCA12CA9TSHR | |
| SCHEMBL20525255 | 0.82 | KDM4E (0.72) | LMNAMAOBCA12CA9TSHR | |
| SCHEMBL15842848 | 0.81 | GPR35 (0.47) | LMNAMAOBCA12CA9TSHR | |
| SCHEMBL28690050 | 0.81 | MAOA (0.68) | MAOBCA12CA9TSHRCA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 80 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260034227-A1 | AZLACTONE-BASED POLYMERS AS A SCAFFOLD FOR DIVERSE APPLICATIONS IN DRUG AND GENE DELIVERY | UNIV MISSISSIPPI (US) | 2026-02-05 | — | — | US | claimed |
| WO-2024020355-A2 | AZLACTONE-BASED POLYMERS AS A SCAFFOLD FOR DIVERSE APPLICATIONS IN DRUG AND GENE DELIVERY | UNIVERSITY OF MISSISSIPPI (US) | 2024-01-25 | — | — | WO | claimed |
| CN-116693466-A | Gallic acid derivative containing thiazole structure and synthesis method and application thereof | 江苏海洋大学 | 2023-09-05 | — | — | CN | claimed |
| CN-115850257-A | Synthetic method of emodin amide derivatives containing coumarin thiazole and application of emodin amide derivatives in resisting marine vibrio | 江苏海洋大学 | 2023-03-28 | — | — | CN | claimed |
| CN-109001345-B | High performance liquid chromatography fluorescence detection method for determining concentration of perfluorooctanoic acid in landfill leachate | 重庆大学 | 2022-06-17 | — | — | CN | claimed |
| CN-114213407-A | 2-pyridyl thiazole hydrazone coumarin derivative chemical sensor, preparation method and application | 江苏海洋大学 | 2022-03-22 | — | — | CN | claimed |
| CN-108774277-B | Thiazole derivative containing glucosamine and coumarin molecules, and preparation method and application thereof | 淮海工学院 | 2021-12-21 | — | — | CN | claimed |
| CN-108558851-B | Coumarin-oxazole-ethylene type alpha-glucosidase inhibitor and preparation method and application thereof | 贵州医科大学 | 2021-03-05 | — | — | CN | claimed |
| CN-108341809-B | Steel rust inhibitor and preparation method and application thereof | 内江师范学院 | 2020-12-22 | — | — | CN | claimed |
| CN-108558843-B | Coumarin-triazole-isatin type compound and preparation method and application thereof | 贵州医科大学 | 2020-12-15 | — | — | CN | claimed |
| CN-108598533-B | Coumarin-based photocyclization crosslinking sulfonated polyimide proton exchange membrane and preparation method thereof | 同济大学 | 2020-11-03 | — | — | CN | claimed |
| US-9127092-B2 | Method for producing polydienes and polydiene copolymers with reduced cold flow | BRIDGESTONE CORPORATION (JP) | 2015-09-08 | — | — | US | claimed |
| US-20140187725-A1 | METHOD FOR PRODUCING POLYDIENES AND POLYDIENE COPOLYMERS WITH REDUCED COLD FLOW | BRIDGESTONE CORPORATION (JP) | 2014-07-03 | — | — | US | claimed |
| EP-0620500-A2 | Resist and pattern formation using the same | HITACHI, LTD. (JP) | 1994-10-19 | — | — | EP | claimed |
| US-20260034227-A1 | AZLACTONE-BASED POLYMERS AS A SCAFFOLD FOR DIVERSE APPLICATIONS IN DRUG AND GENE DELIVERY | UNIV MISSISSIPPI (US) | 2026-02-05 | — | — | US | disclosed |
| CN-118834490-A | Photo-crosslinkable perfluorinated ion membrane and preparation method thereof | 上海交通大学 | 2024-10-25 | — | — | CN | disclosed |
| US-20240327655-A1 | DYE-LABELED POLYMERS AND METHODS FOR PREPARING SAME | DEBOGY MOLECULAR, INC. (US) | 2024-10-03 | — | — | US | disclosed |
| EP-0620500-A2 | Resist and pattern formation using the same | HITACHI, LTD. (JP) | 1994-10-19 | — | — | EP | disclosed |
| US-4001224-A | 4-SUBSTITUTED-2, 3-DIHYDRO-1-BENZOXEPIN-3, 5-DIONES AND TAUTOMERS | WARNER-LAMBERT COMPANY (US) | 1977-01-04 | — | — | US | disclosed |
| US-3991082-A | 4-Substituted-2,3-dihydro-1-benzoxepin-3,5-diones and tautomers | WARNER-LAMBERT COMPANY (US) | 1976-11-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260034227-A1 | AZLACTONE-BASED POLYMERS AS A SCAFFOLD FOR DIVERSE APPLICATIONS IN DRUG AND GENE DELIVERY | SARS1, ATF4, PSD | LMNA 332/4885MAOB 4473/4885CA12 2851/4885 |
| US-20240327655-A1 | DYE-LABELED POLYMERS AND METHODS FOR PREPARING SAME | ALG1, CD99, GUSB | LMNA 1610/4885MAOB 1060/4885CA12 514/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.